ArticleFrontiers in nutrition2026
Stage-specific associations of nutrition-related surrogate insulin resistance indices across the chronic kidney disease continuum: evidence from a Chinese cohort.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Comparative longitudinal evidence on how different surrogate insulin resistance (IR) indices relate to chronic kidney disease (CKD) onset and subsequent renal deterioration remains limited. This study aimed to evaluate the associations of surrogate IR indices with CKD incidence, progression, and outcomes. Methods: This retrospective cohort study included participants from the Dalian Health Management Cohort, in which 12 surrogate IR indices were calculated. The primary outcome was incident CKD, while secondary outcomes included rapid kidney function decline (RKFD) and adverse renal outcomes. Kaplan-Meier analysis compared the CKD incidence across quartiles. Associations between surrogate IR indices and renal outcomes were evaluated using Cox proportional hazards and logistic regression models. Dose-response relationships were assessed using restricted cubic splines, and predictive performance was evaluated using time-dependent receiver operating characteristic curves and associated metrics. Results: Among 48,304 participants, 1,092 incident CKD cases (2.26%) were identified over a median follow-up of 4.74 years. Kaplan-Meier curves showed increasing CKD risk across the IR quartiles. Quartile-based analyses showed progressively higher incident CKD risk with increasing levels of the evaluated surrogate IR indices (all Conclusion: Surrogate IR indices were higher in groups with poorer renal outcomes. Indices emphasizing visceral adiposity-related components showed relatively stronger associations with incident CKD, whereas indices incorporating glucose-lipid metabolic and overall adiposity components showed relatively stronger associations with later renal deterioration. TyG-WC may serve as a simple marker for early risk identification and stratification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.